Skip to main content
Neda Laiteerapong, MD, Internal Medicine, Chicago, IL, University of Chicago Medical Center

NedaLaiteerapongMDM.S.

Internal Medicine Chicago, IL

Associate Professor

Overview of Dr. Laiteerapong

I am a practicing board certified general internist and health services and outcomes researcher specializing in diabetes simulation modeling and longitudinal epidemiology. I care for adult patients in the outpatient and inpatient settings and teach and mentor trainees. My research is in how to individualize new models of care for patients with diabetes and other chronic conditions. I also lead a team that is integrating behavioral health in primary care.

Education & Training

  • University of Chicago
    University of ChicagoFellowship, Internal Medicine, 2009 - 2012
  • University of Chicago
    University of ChicagoMS, Health Studies, 2009 - 2012
  • University of Chicago
    University of ChicagoM.S., Clinical Professionals, 2009 - 2012
  • Loyola Medicine MacNeal Hospital
    Loyola Medicine MacNeal HospitalChief Residency, Internal Medicine, 2008 - 2009
  • University of Chicago
    University of ChicagoResidency, Internal Medicine, 2005 - 2008
  • Boston University School of Medicine
    Boston University School of MedicineClass of 2005
  • Boston University
    Boston UniversityB.A., Major in Biology, Minor in Art History, Magna cum Laude, 1997 - 2001

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2008 - 2026
  • American Board of Internal Medicine Internal Medicine
  • American Board of Preventive Medicine Clinical Informatics

Awards, Honors, & Recognition

  • Junior Faculty Scholar Bucksbaum Institute
  • Junior Faculty Scholar Award Bucksbaum Institute, University of Chicago, 2017
  • Best Scientific Abstracts Oral Presentation, “The legacy effect in type 2 diabetes: Impact of duration and intensity of early glycemic control on future complications (The Diabetes & Aging Study)” Midwest Society of General Internal Medicine, 2016
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Guidelines on Glycemic Targets for Persons with Type 2 Diabetes—Reply  
    Neda Laiteerapong, Andrew M Davis, Elizabeth L Tung, JAMA
  • Cost-effectiveness of individualized glycemic control in US adults with Type 2 diabetes  
    Laiteerapong N, Cooper JM, Naylor RN, Winn A, Skandari M, Clarke PM, Huang ES, Ann Intern Med, 1/1/2017
  • Impact of Work Conditions and Minority Patient Populations on Quality and Error  
    Varkey AB, Manwell LB, Brown RL, Montague E, Laiteerapong N, Burgess D, Ibrahim S, Health Services Research and Managerial Epidemiology, 1/1/2016

Books/Book Chapters

Abstracts/Posters

  • Physician decision-making regarding glycemic control for patients with type 2 diabetes: Individualizing just above and below an A1C of 7%
    Laiteerapong N, Ham S, Quinn MT, Nathan AG, Huang ES, Midwest Society of General Internal Medicine, Chicago, IL, 1/1/2017
  • Associations Between Behavioral Health Integration and Diabetes Outcomes in Midwest Community Health Centers
    Laiteerapong N, Staab E, Quinn MT, Schaefer C, Li M, Gedeon S, Burnet D, Campbell A, Chin MH, Academy Health, New Orleans, LA, 1/1/2017
  • The legacy effect in type 2 diabetes: Impact of duration and intensity of early glycemic control on future complications (The Diabetes & Aging Study)
    Laiteerapong N, Gao Y, Moffet HH, Ham SA, Liu JY, Huang ES, Karter AJ, American Diabetes Association, Annual Meeting; Midwest Society of General Internal Medicine, New Orleans, LA, 2016; Cleveland, OH, 2016, 1/1/2016

Lectures

  • Moving Toward Team-Based Care in Primary Care Clinics 
    1/1/2017
  • Long-term Benefits of Early Intensive Glycemic Control in Patients with Type 2 Diabetes: Implications of the Legacy Effect 
    1/1/2017
  • There’s A NEW URGENCY to get Glycemic Control in One Year! 
    1/1/2017
  • Join now to see all

Other

Press Mentions

  • Sky-High Cost of SGLT2i and GLP1 Agonists Deter First-Line Use
    Sky-High Cost of SGLT2i and GLP1 Agonists Deter First-Line UseOctober 5th, 2022
  • Obesity Prevalence Varies Significantly for Asian American Subgroups
    Obesity Prevalence Varies Significantly for Asian American SubgroupsOctober 3rd, 2022
  • Primary Care Doctors Need 27 Hours a Day to Do Their Best Work -News Forest
    Primary Care Doctors Need 27 Hours a Day to Do Their Best Work -News ForestAugust 11th, 2022
  • Join now to see all

Grant Support

  • Determinants Of Quality Of Life In Elderly Adults With DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2011

Professional Memberships

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    BCBS Blue Card PPO
    BCBS Illinois PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Cofinity PPO
    First Health PPO
    Great West PPO
    HealthLink PPO
    Humana ChoiceCare Network PPO
    Multiplan PHCS PPO
    Multiplan PPO
    Sagamore Health Plus
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment